Active Transdermal Delivery Systems


October 15, 2011
SKU: GRST6567377
License type:
Analyzes and evaluates active transdermal products and assesses the market potential for existing and probable future products

Analyzes product designs, technologies and market development issues

Provides detailed descriptions of transdermal delivery market segments, market demographics, and business strategies

Charts product sales data, market share, and forecasts to 2015

Profiles active transdermal delivery companies, their product development activities, business strategies, and corporate alliances and affiliations

Assesses the importance of pharma-device alliances and design partnerships on future active transdermal products

Evaluates the impact of economic, technology, and regulatory factors on transdermal drug delivery markets



More Transdermal & Implantable reports by Greystone Research Associates

Microneedle Drug Delivery by Greystone Research Associates
Microneedle technology is an enabling technology base for the development of needles with micro scale cross sectional dimensions and added functionality. The microneedles can be ...
Transdermal Pain Management to 2015 Markets, Demand Factors, Opportunities and Forecasts by Greystone Research Associates
As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing ...
Continuous Glucose Monitors by Greystone Research Associates
The convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Continuous glucose ...
Transdermal Skin Patches by Greystone Research Associates
Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. New ...
See all reports like this >>